PFO
RBOT

Pathstone Family Office’s Vicarious Surgical RBOT Stock Holding History

Pathstone Family Office’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$20.2K Sell
1,141
-34
-3% -$1.24K ﹤0.01% 1648
2023
Q2 		$64.5K Buy
+1,175
New +$74.9K ﹤0.01% 1211

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HVCM
Hel Ved Capital Management Central, Hong Kong $844M AUM 191.74% 1-Year Est. Return

Pathstone Family Office's RBOT Position: Q3 2023 in Review

Pathstone Family Office reduced its Vicarious Surgical (RBOT) stake by 2.9% in Q3 2023, selling an estimated $1.24K and leaving 1,141 shares worth $20.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1648.

Pathstone Family Office first reported a position in RBOT in Q2 2023 and has held it in 2 quarters since. The position peaked at $64.5K in Q2 2023. 83 funds tracked by Wall St. Rank hold RBOT as of Q3 2023.

  • Pathstone Family Office held 1,141 shares of Vicarious Surgical worth $20.2K as of Q3 2023.
  • Pathstone Family Office sold 34 Vicarious Surgical shares in Q3 2023, an estimated $1.24K.
  • Vicarious Surgical made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1648 holding.
  • Pathstone Family Office first reported a position in Vicarious Surgical in Q2 2023 and has held it in 2 quarters since.
  • Pathstone Family Office's Vicarious Surgical position peaked at $64.5K in Q2 2023.
  • 83 funds tracked by Wall St. Rank held Vicarious Surgical as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.